Reduced kidney function as a risk factor for incident heart failure: The Atherosclerosis Risk in Communities (ARIC) Study

Journal of the American Society of Nephrology

Volumn 18, Issue 4, 2007, Pages 1307-1315

  Kottgen, Anna ^a,b   Russell, Stuart D ^c   Loehr, Laura R ^d   Crainiceanu, Ciprian M ^a   Rosamond, Wayne D ^d   Chang, Patricia P ^d,e   Chambless, Lloyd E ^d   Coresh, Josef ^a,b,c,f  

^a JOHNS HOPKINS BLOOMBERG SCHOOL OF PUBLIC HEALTH   (United States)

^b JOHNS HOPKINS UNIVERSITY   (United States)

^c JOHNS HOPKINS UNIVERSITY SCHOOL OF MEDICINE   (United States)

^d IL   (United States)

^e UNIVERSITY OF NORTH CAROLINA SCHOOL OF MEDICINE   (United States)

^f NONE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; ARTICLE; CARDIOVASCULAR RISK; DEATH; DEMOGRAPHY; DISEASE SEVERITY; FEMALE; FOLLOW UP; GLOMERULUS FILTRATION RATE; HEART FAILURE; HIGH RISK POPULATION; HOSPITALIZATION; HUMAN; INCIDENCE; INTERNATIONAL CLASSIFICATION OF DISEASES; ISCHEMIC HEART DISEASE; KIDNEY FAILURE; KIDNEY FUNCTION; MAJOR CLINICAL STUDY; MALE; MORBIDITY; MORTALITY; PREVALENCE; PRIORITY JOURNAL; RISK FACTOR;

EID: 34047208743     PISSN: 10466673     EISSN: None     Source Type: Journal    
DOI: 10.1681/ASN.2006101159     Document Type: Article

References (48)

1. Mann JF, Gerstein HC, Pogue J, Bosch J, Yusuf S: Renal insufficiency as a predictor of cardiovascular outcomes and the impact of ramipril: The HOPE randomized trial. Ann Intern Med 134: 629-636, 2001
2. Manjunath G, Tighiouart H, Ibrahim H, MacLeod B, Salem DN, Griffith JL, Coresh J, Levey AS, Sarnak MJ: Level of kidney function as a risk factor for atherosclerotic cardiovascular outcomes in the community. J Am Coll Cardiol 41: 47-55, 2003
3. Fried LF, Shlipak MG, Crump C, Bleyer AJ, Gottdiener JS, Kronmal RA, Kuller LH, Newman AB: Renal insufficiency as a predictor of cardiovascular outcomes and mortality in elderly individuals. J Am Coll Cardiol 41: 1364-1372, 2003
4. Sarnak MJ, Levey AS, Schoolwerth AC, Coresh J, Culleton B, Hamm LL, McCullough PA, Kasiske BL, Kelepouris E, Klag MJ, Parfrey P, Pfeffer M, Raij L, Spinosa DJ, Wilson PW; American Heart Association Councils on Kidney in Cardiovascular Disease, High Blood Pressure Research, Clinical Cardiology, and Epidemiology and Prevention: Kidney disease as a risk factor for development of cardiovascular disease: A statement from the American Heart Association Councils on Kidney in Cardiovascular Disease, High Blood Pressure Research, Clinical Cardiology, and Epidemiology and Prevention. Circulation 108: 2154-2169, 2003
5. Shlipak MG, Sarnak MJ, Katz R, Fried LF, Seliger SL, Newman AB, Siscovick DS, Stehman-Breen C: Cystatin C and the risk of death and cardiovascular events among elderly persons. N Engl J Med 352: 2049-2060, 2005
6. Rahman M, Pressel S, Davis BR, Nwachuku C, Wright JT Jr, Whelton PK, Barzilay J, Batuman V, Eckfeldt JH, Farber MA, Franklin S, Henriquez M, Kopyt N, Louis GT, Saklayen M, Stanford C, Walworth C, Ward H, Wiegmann T; ALLHAT Collaborative Research Group: Cardiovascular outcomes in high-risk hypertensive patients stratified by baseline glomerular filtration rate. Ann Mem Med 144: 172-180, 2006
7. Astor BC, Coresh J, Heiss G, Pettitt D, Sarnak MJ: Kidney function and anemia as risk factors for coronary heart disease and mortality: The Atherosclerosis Risk in Communities (ARIC) Study. Am Heart J 151: 492-500, 2006
8. Coresh J, Astor BC, Greene T, Eknoyan G, Levey AS: Prevalence of chronic kidney disease and decreased kidney function in the adult US population: Third National Health and Nutrition Examination Survey. Am J Kidney Dis 41: 1-12, 2003
9. Gottdiener JS, Arnold AM, Aurigemma GP, Polak JF, Tracy RP, Kitzman DW, Gardin JM, Rutledge JE, Boineau RC: Predictors of congestive heart failure in the elderly: The Cardiovascular Health Study. J Am Coll Cardiol 35: 1628-1637, 2000
10. Sarnak MJ, Katz R, Stehman-Breen CO, Fried LF, Jenny NS, Psaty BM, Newman AB, Siscovick D, Shlipak MG; Cardiovascular Health Study: Cystatin C concentration as a risk factor for heart failure in older adults. Ann Intern Med 142: 497-505, 2005
11. Bibbins-Domingo K, Chertow GM, Fried LF, Odden MC, Newman AB, Kritchevsky SB, Harris TB, Satterfield S, Cummings SR, Shlipak MG: Renal function and heart failure risk in older black and white individuals: The Health, Aging, and Body Composition study. Arch Intern Med 166: 1396-1402, 2006
12. Bibbins-Domingo K, Lin F, Vittinghoff E, Barrett-Connor E, Hulley SB, Grady D, Shlipak MG: Predictors of heart failure among women with coronary disease. Circulation 110: 1424-1430, 2004
13. Chae CU, Albert CM, Glynn RJ, Guralnik JM, Curhan GC: Mild renal insufficiency and risk of congestive heart failure in men and women ≥70 years of age. Am J Cardiol 92: 682-686, 2003
14. Dries DL, Exner DV, Domanski MJ, Greenberg B, Stevenson LW: The prognostic implications of renal insufficiency in asymptomatic and symptomatic patients with left ventricular systolic dysfunction. J Am Coll Cardiol 35: 681-689, 2000
15. Smith GL, Lichtman JH, Bracken MB, Shlipak MG, Phillips CO, DiCapua P, Krumholz HM: Renal impairment and outcomes in heart failure: Systematic review and metaanalysis. J Am Coll Cardiol 47: 1987-1996, 2006
16. Culleton BF, Larson MG, Wilson PW, Evans JC, Parfrey PS, Levy D: Cardiovascular disease and mortality in a community-based cohort with mild renal insufficiency. Kidney Int 56: 2214-2219, 1999
17. Forman DE, Butler J, Wang Y, Abraham WT, O'Connor CM, Gottlieb SS, Loh E, Massie BM, Rich MW, Stevenson LW, Young JB, Krumholz HM: Incidence, predictors at admission, and impact of worsening renal function among patients hospitalized with heart failure. J Am Coll Cardiol 43: 61-67, 2004
18. Gottlieb SS, Abraham W, Butler J, Forman DE, Loh E, Massie BM, O'Connor CM, Rich MW, Stevenson LW, Young J, Krumholz HM: The prognostic importance of different definitions of worsening renal function in congestive heart failure. J Card Fail 8: 136-141, 2002
19. Khan NA, Ma I, Thompson CR, Humphries K, Salem DN, Sarnak MJ, Levin A: Kidney function and mortality among patients with left ventricular systolic dysfunction. J Am Soc Nephrol 17: 244-253, 2006
20. Stevens LA, Coresh J, Greene T, Levey AS: Assessing kidney function: Measured and estimated glomerular filtration rate. N Engl J Med 354: 2473-2483, 2006
21. The Atherosclerosis Risk in Communities (ARIC) Study: Design and objectives. The ARIC investigators. Am J Epidemiol 129: 687-702, 1989
22. National Heart, Lung, and Blood Institute Atherosclerosis Risk in Communities (ARIC) Study. Operations Manual 7: Blood Collecting and Processing, Bethesda, National Heart, Lung, and Blood Institute, 1988
23. National Heart, Lung, and Blood Institute Atherosclerosis Risk in Communities (ARIC) Study. Operations Manual 8: Lipid and Lipoprotein Determinations, Bethesda, National Heart, Lung, and Blood Institute, 1987
24. National Heart, Lung, and Blood Institute Atherosclerosis Risk in Communities (ARIC) Study. Operations Manual 10: Clinical Chemistry Determinations, Bethesda, National Heart, Lung, and Blood Institute, 1987
25. National Heart, Lung, and Blood Institute Atherosclerosis Risk in Communities (ARIC) Study. Operations Manual 6a,b: Ultrasound Assessment, Scanning, Reading, Bethesda, National Heart, Lung, and Blood Institute, 1987, 1989
26. Levey AS, Bosch JP, Lewis JB, Greene T, Rogers N, Roth D: A more accurate method to estimate glomerular filtration rate from serum creatinine: A new prediction equation. Modification of Diet in Renal Disease Study Group. Ann Intern Med 130: 461-470, 1999
27. Coresh J, Astor BC, McQuillan G, Kusek J, Greene T, Van Lente F, Levey AS: Calibration and random variation of the serum creatinine assay as critical elements of using equations to estimate glomerular filtration rate. Am J Kidney Dis 39: 920-929, 2002
28. Eriksson H, Caidahl K, Larsson B, Ohlson LO, Welin L, Wilhelmsen L, Svardsudd K: Cardiac and pulmonary causes of dyspnoea: Validation of a scoring test for clinical-epidemiological use-The Study of Men Born in 1913. Eur Heart J 8: 1007-1014, 1987
29. Wilhelmsen L, Eriksson H, Svardsudd K, Caidahl K: Improving the detection and diagnosis of congestive heart failure. Eur Heart J 10[Suppl C]: 13-18, 1989
30. National Kidney Foundation: K/DOQI clinical practice guidelines for chronic kidney disease: Evaluation, classification, and stratification. Am J Kidney Dis 39: S1-S266, 2002
31. Carroll RJ, Ruppert D, Stefanski LA, Crainiceanu C: Measurement Error in Nonlinear Models: A Modern Perspective, 2nd Ed., New York, Chapman & Hall CRC, 2006
32. StataCorp: Stata Statistical Software: Release 9.0 [computer program], College Station, TX, StataCorp., 2005
33. Epanechnikov VA: Nonparametric estimation of a multivariate probability density. Theory of Probability and Its Applications 14: 153-158, 1969
34. Muntner P, Coresh J, Smith JC, Eckfeldt J, Klag MJ: Plasma lipids and risk of developing renal dysfunction: The Atherosclerosis Risk in Communities Study. Kidney Int 58: 293-301, 2000
35. Garg AX, Clark WF, Haynes RB, House AA: Moderate renal insufficiency and the risk of cardiovascular mortality: Results from the NHANES I. Kidney Int 61: 1486-1494, 2002
36. Coresh J, Byrd-Holt D, Astor BC, Briggs JP, Eggers PW, Lacher DA, Hostetter TH: Chronic kidney disease awareness, prevalence, and trends among US adults, 1999 to 2000. J Am Soc Nephrol 16: 180-188, 2005
37. Hillege HL, Nitsch D, Pfeffer MA, Swedberg K, McMurray JJ, Yusuf S, Granger CB, Michelson EL, Ostergren J, Cornel JH, de Zeeuw D, Pocock S, van Veldhuisen DJ; Candesartan in Heart Failure Assessment of Reduction in Mortality and Morbidity (CHARM) Investigators: Renal function as a predictor of outcome in a broad spectrum of patients with heart failure. Circulation 113: 671-678, 2006
38. He J, Ogden LG, Bazzano LA, Vupputuri S, Loria C, Whelton PK: Risk factors for congestive heart failure in US men and women: NHANES I epidemiologic follow-up study. Arch Intern Med 161: 996-1002, 2001
39. Barker WH, Mullooly JP, Getchell W: Changing incidence and survival for heart failure in a well-defined older population, 1970-1974 and 1990-1994. Circulation 113: 799-805, 2006
40. Gheorghiade M, Bonow RO: Chronic heart failure in the United States: A manifestation of coronary artery disease. Circulation 97: 282-289, 1998
41. Coresh J, Astor B, Sarnak MJ: Evidence for increased cardiovascular disease risk in patients with chronic kidney disease. Curr Opin Nephrol Hypertens 13: 73-81, 2004
42. McCullough PA: Why is chronic kidney disease the "spoiler" for cardiovascular outcomes? J Am Coll Cardiol 41: 725-728, 2003
43. Go AS, Yang J, Ackerson LM, Lepper K, Robbins S, Massie BM, Shlipak MG: Hemoglobin level, chronic kidney disease, and the risks of death and hospitalization in adults with chronic heart failure: The Anemia in Chronic Heart Failure: Outcomes and Resource Utilization (ANCHOR) Study. Circulation 113: 2713-2723, 2006
44. Hillege HL, Fidler V, Diercks GF, van Gilst WH, de Zeeuw D, van Veldhuisen DJ, Gans RO, Janssen WM, Grobbee DE, de Jong PE; Prevention of Renal and Vascular End Stage Disease (PREVEND) Study Group: Urinary albumin excretion predicts cardiovascular and noncardiovascular mortality in general population. Circulation. 106: 1777-1782, 2002
45. de Zeeuw D, Parving HH, Henning RH: Microalbuminuria as an early marker for cardiovascular disease. J Am Soc Nephrol 17: 2100-2105, 2006
46. Sun Y: The renin-angiotensin-aldosterone system and vascular remodeling. Congest Heart Fail 8: 11-16, 2002
47. Fonseca C, Oliveira AG, Mota T, Matias F, Morais H, Costa C, Ceia F; EPICA Investigators: Evaluation of the performance and concordance of clinical questionnaires for the diagnosis of heart failure in primary care. Eur J Heart Fail 6: 813-820, 821-822, 2004
48. Coresh J, Stevens L: Kidney function estimating equations: Where do we stand? Curr Opin Nephrol Hypertens 15: 276-284, 2006